Optimizing Rare Disease Outcomes Through eCOA Technology And Training

By Susan M. Dallabrida, Ph.D.

The successful development of new rare disease treatments doesn’t have to be rare. Clinical trial sponsors who incorporate effective data capture strategies to optimize outcome measurement reduce clinical data risks, improve data quality and strengthen their risk management initiatives through near real-time data access ─ all of which produces a more accurate picture of treatment benefit and keeps development plans on track and on budget.

Read how utilizing electronic data capture systems ─ including eCOA ─ and training site raters, subjects and caregivers are important tools to ensure high quality data capture in rare disease research.